MRI-Guided Prostate Biopsy of Native and Recurrent Prostate Cancer

• Published in: Seminars in interventional radiology Vol. 33; no. 3; pp. 196 - 205
• Main Authors: Woodrum, David A, Gorny, Krzysztof R, Greenwood, Bernadette, Mynderse, Lance A
• Format: Journal Article
• Language: English
• Published: United States Thieme Medical Publishers 01-09-2016
• Series: Men's Health
• Subjects: Review; MRI targeted biopsy; prostate cancer; interventional radiology; MRI; needle biopsy
• ISSN: 0739-9529; 1098-8963
• DOI: 10.1055/s-0036-1586151

Prostate cancer is the most commonly diagnosed noncutaneous cancer and second-leading cause of death in men. Many patients with clinically organ-confined prostate cancer undergo definitive, curative treatment of the whole gland with either radical prostatectomy or radiation therapy. However, many men are reluctant to take the definitive step due to potential morbidity associated with either therapy. A growing interest in active surveillance or focal therapy has emerged as realistic alternatives for many patients. With each of these management strategies, it is critical to accurately quantify and stage the cancer with improved biopsy targeting and more precise imaging with magnetic resonance imaging (MRI). Furthermore, having dependable prostate imaging allows for targeted biopsies to improve the yield of clinically significant prostate cancer and decrease detection of indolent prostate cancer. MRI-guided targeted biopsy techniques include cognitive MRI/transrectal ultrasound fusion biopsy, in-bore transrectal targeted biopsy using a calibrated guidance device, and in-bore direct MR-guided transperineal biopsy with a software-based transperineal grid template. Herein we present a contemporary review of MRI-guided targeted biopsy techniques for new and recurrent cancerous foci of the prostate.